A 15-year relationship between China and Quintiles was enhanced as the multinational CRO announced that it will build its new regional headquarters in Shanghai and establish a partnership with the Shanghai Clinical Research Center (SCRC) to provide lab testing capabilities for local customers.
The move further establishes China as a leading country for contract research, growth that is being propelled by its large population. "With its burgeoning economy and growing healthcare needs for its 1.3 billion citizens, China exemplifies the opportunities and challenges of the New Health," said Quintiles Executive Chairman Dennis Gillings in a statement. "By broadening our investment and infrastructure here, Quintiles is ready to partner with our biopharma customers as they look to realize China's potential."
Quintiles will invest $14 million to build a 43,000-square-foot office that is expected to house more than 450 employees in the next 5 years.
The Shanghai center is not the only new project Quintiles has in kicked-off in China recently. Last year, Quintiles and SCRC launched Kun Tuo, their own Chinese contract research organization, and in January, announced plans to create a business process outsourcing and project management center in the city of Dalian.
- read the release